Active

Tranexamic Acid

INCI: Tranexamic Acid

A small synthetic molecule with strong evidence for stubborn hyperpigmentation and melasma. Brightens without sun-sensitizing the skin.

Usage rate 2-5%
Phase Water phase (cool-down)
Solubility Water-soluble

Overview

Tranexamic Acid is a small synthetic amino acid analog, originally developed as a systemic medication for excessive bleeding (it interferes with the breakdown of fibrin clots). Cosmetic researchers in Japan discovered in the 1990s that topical tranexamic acid has a distinct second effect: it reduces the inflammatory signaling between skin cells and the melanin-producing melanocytes underneath, particularly the signaling that drives stubborn hyperpigmentation conditions like melasma.

It is supplied as a fine white crystalline powder, fully water-soluble, with no scent. The cosmetic form has no relationship to the prescription dosing of the oral medication — the topical use does not affect blood clotting because the active does not penetrate to the systemic circulation in meaningful amounts.

In the body of published research, topical tranexamic acid at 3-5% over 8-12 weeks shows measurable improvement in melasma, post-inflammatory hyperpigmentation, and sun-induced dark patches. It has become one of the better-evidenced cosmetic actives for the specific problem of melasma — a stubborn pigmentation pattern that most other brighteners struggle to shift.

Shelf life as raw material is 2-3 years stored cool and dark; in finished formula it is stable for 18-24 months across a broad pH range.

What it does in a formula

Tranexamic acid interferes with the plasmin-driven signaling between keratinocytes and melanocytes. In skin with chronic low-grade inflammation (sun exposure, hormonal melasma, friction from cleansing), keratinocytes send signals that tell melanocytes to make more melanin. Tranexamic acid quiets that signal, reducing the over-production of melanin without poisoning the melanocyte (unlike older bleaching agents).

The effect is gentle and slow — visible improvement over 8-12 weeks of consistent twice-daily use — but consistent across different pigmentation patterns.

It does not interact with sun exposure (no photosensitivity), works at neutral pH (no stinging), and combines well with most other actives including niacinamide and vitamin C.

How to use

Cool-down phase, below 40 C. Dissolves readily in the water phase or a cooled emulsion. The dissolution is mildly endothermic — the solution may feel slightly cool during mixing.

Usage rates by product type:

  • Melasma-positioning serums: 3-5%
  • General brightening serums: 2-5%
  • Day moisturizers (brightening claim): 2-3%
  • Eye creams (for pigmented dark circles): 2-3%
  • Spot treatments: 3-5%
  • Body lotions for tone evening: 1-3%

The standard rate is 3%. Above 5% the cost climbs without proportional benefit.

Best for / Worst for

Best for: melasma, post-inflammatory hyperpigmentation, sun-induced dark patches, brown under-eye circles, formulators wanting brightening evidence for a specific condition rather than general “brighter skin” claims, sensitive skin types that cannot tolerate vitamin C or strong AHAs.

Worst for: anhydrous balms (water-soluble), redness rather than pigment (it does not affect vascular concerns), beginners who confuse it with hydroquinone or stronger pigmentation-fighting medications.

Common pitfalls

Expecting overnight results. Realistic timeline is 8-12 weeks of consistent twice-daily use before visible change. Melasma in particular is stubborn.

Treating it as a hydroquinone substitute. Tranexamic acid is gentler and slower than hydroquinone. For very severe melasma, dermatologist-prescribed treatments may still be needed.

Skipping daily sunscreen. Without sun protection, the pigmentation problem keeps regenerating. Daily SPF use is essential alongside tranexamic acid.

Combining with too many other brighteners. Stacking tranexamic acid + vitamin C + arbutin + kojic acid + niacinamide in one formula is unnecessary. Pick two or three complementary actives at effective doses.

Confusing topical and oral safety profiles. The systemic prescription dose can affect clotting; the topical cosmetic use does not. Two completely different contexts.

Substitutes

  • Alpha Arbutin — gentle brightener via different mechanism.
  • Niacinamide — broad-spectrum active for tone and barrier.
  • Vitamin C (any form) — classic brightening active.
  • Azelaic Acid — anti-pigmentation acid with anti-inflammatory effects.
  • Kojic Acid — older brightening active for similar purposes.